0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},f=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(f(),setInterval((function(){f()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var m=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===m&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};
NasdaqGS - Delayed Quote • USD
16.11 +0.96 (+6.34%)
At close: June 18 at 4:00 PM EDT
16.17 +0.06 (+0.37%)
Pre-Market: 4:17 AM EDT
9/21 12:03 PM
Date | |
Close | |
Open | |
High | |
Low | |
Volume | |
- Previous Close 15.15
- Open 15.18
- Bid --
- Ask --
- Day's Range 15.15 - 16.17
- 52 Week Range 14.62 - 32.00
- Volume 19,132,876
- Avg. Volume 12,268,648
- Market Cap (intraday) 13.898B
- Beta (5Y Monthly) 0.77
- PE Ratio (TTM) --
- EPS (TTM) -7.00
- Earnings Date Jun 27, 2024
- Forward Dividend & Yield 1.00 (6.21%)
- Ex-Dividend Date May 20, 2024
- 1y Target Est 21.58
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com
330,000
Full Time Employees
August 31
Fiscal Year Ends
Pharmaceutical Retailers
Industry
More about Walgreens Boots Alliance, Inc.
Recent News: WBA
View More
Corporate Changes & Voting Matters
Periodic Financial Reports
Tender Offer/Acquisition Reports
View More
Performance Overview: WBA
Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is .
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
WBAWalgreens Boots Alliance, Inc.
Mkt Cap 13.898B
Industry Pharmaceutical Retailers
RADCQRite Aid Corporation
Mkt Cap 14.174M
Industry Pharmaceutical Retailers
PETSPetMed Express, Inc.
Mkt Cap 89.021M
Industry Pharmaceutical Retailers
MEDSTRxADE HEALTH, Inc.
Mkt Cap 13.571M
Industry Pharmaceutical Retailers
HITIHigh Tide Inc.
Mkt Cap 202.723M
Industry Pharmaceutical Retailers
LFLYLeafly Holdings, Inc.
Mkt Cap 5.544M
Industry Pharmaceutical Retailers
BIMIBIMI Holdings Inc.
Mkt Cap 18.847M
Industry Pharmaceutical Retailers
HITI.VHigh Tide Inc.
Mkt Cap CAD 276.733M
Industry Pharmaceutical Retailers
PINK.PRPilulka Lékárny a.s.
Mkt Cap CZK 365.445M
Industry Pharmaceutical Retailers
CJJDChina Jo-Jo Drugstores, Inc.
Mkt Cap 10.937M
Industry Pharmaceutical Retailers
RADLYRaia Drogasil S.A.
Mkt Cap 7.127B
Industry Pharmaceutical Retailers
Statistics: WBA
View More
As of 6/18/2024
Market Cap
13.90B
Enterprise Value
46.85B
Trailing P/E
--
Forward P/E
4.98
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
1.03
Enterprise Value/Revenue
0.32
Enterprise Value/EBITDA
--
Profitability and Income Statement
Balance Sheet and Cash Flow
View More
Research Analysis: WBA
View More
View More
CVS CVS Health Corporation
KHC The Kraft Heinz Company
UNH UnitedHealth Group Incorporated
KMB Kimberly-Clark Corporation
O Realty Income Corporation
CL Colgate-Palmolive Company
BMY Bristol-Myers Squibb Company
LOW Lowe's Companies, Inc.
FAQs
Is Walgreens Boots Alliance stock a Buy, Sell or Hold? Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 6 buy ratings, 35 hold ratings, and 13 sell ratings.
What is the future of WBA stock? ›
WBA Stock 12 Month Forecast
Based on 12 Wall Street analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $13.67 with a high forecast of $22.00 and a low forecast of $9.00.
What is the target price for Walgreens Boots Alliance? ›
Based on short-term price targets offered by 15 analysts, the average price target for Walgreens Boots Alliance comes to $13.00. The forecasts range from a low of $7.00 to a high of $22.00. The average price target represents an increase of 23.11% from the last closing price of $10.56.
What is the difference between Walgreens and Walgreens Boots Alliance? ›
Walgreens Boots Alliance, Inc.
(WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies.
How much debt does Walgreens Boots Alliance have? ›
Total debt on the balance sheet as of May 2024 : $32.67 B
According to Walgreens Boots Alliance's latest financial reports the company's total debt is $32.67 B.
What is the dividend growth rate for Walgreens Boots Alliance? ›
During the past 12 months, Walgreens Boots Alliance's average Dividends Per Share Growth Rate was -24.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year.
Who owns most of WBA stock? ›
Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, Capital World Investors, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Geode Capital Management, Llc, VFINX - Vanguard 500 Index Fund Investor Shares, Invesco Ltd., Invesco Qqq Trust, Series 1, and VIMSX - Vanguard Mid ...
What is Walgreens stock prediction for 2025? ›
According to analysts, WBA price target is 12.57 USD with a max estimate of 22.00 USD and a min estimate of 7.00 USD.
Does WBA pay a monthly dividend? ›
Walgreens Boots Alliance, Inc. ( WBA ) pays dividends on a quarterly basis. The next dividend payment is planned on September 12, 2024 .
Who is Walgreens Boots Alliance competitor? ›
Performance Comparison
- WBA. Walgreens Boots Alliance.
- CVS. CVS Health.
- GDRX. GoodRx Holdings.
- MCK. McKesson.
- COR. Cencora.
Walgreens Boots Alliance WBA is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company's earnings outlook.
What brands are under the Walgreens Boots Alliance? ›
WBA employs more than 331,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.
What is Walgreens Boots Alliance Inc rating? ›
Downgraded To 'BB' On Operating Difficulty; Outlook Negative. Walgreens Boots Alliance Inc. recently reported third-quarter results for the period ended May 31, 2024 and fiscal 2025 guidance notably below our expectations.
Is Walgreens owned by Walmart? ›
Walgreens is a public corporation, so it is owned by the shareholders. You can look up the management, CEO, CFO, COO, and all those other details on the web. It was started in 1901 by “pop” Walgreen and grew from there. The “Waltons” were not involved.
How many employees does Walgreens Boots Alliance have? ›
WBA employs approximately 330,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company, and Benavides in Mexico.
What is Walgreens stock price forecast for 2024? ›
The forecasted Walgreens Boots price at the end of 2024 is $15.34 - and the year to year change -26%. The rise from today to year-end: +27%.
What is Walgreens Boots Alliance ranked? ›
As of August 2024 Walgreens Boots Alliance has a market cap of ₹775.70 Billion. This makes Walgreens Boots Alliance the world's 1752th most valuable company by market cap according to our data.
What is Walgreens boots strategy? ›
Embracing a consumer-centric, technology-enabled business model, WBA is poised to deliver improved health outcomes at lower costs. The segment includes a majority stake in VillageMD, a provider of value-based care, and other assets like Shields Health Solutions and CareCentrix.